A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only three medications are approved by the FDA to treat the condition. Those drugs have uneven effectiveness, and health care providers’ lack of familiarity with them contributes to low use.
This article was originally published on MedicalXpress.com

